Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
December 2015

Cariprazine (Vraylar)
The US Food and Drug Administration has approved the antipsychotic cariprazine (Vraylar) to treat schizophrenia and bipolar disorder in adults.

Antidepressants and PPHN
Recent research adds evidence that the use of selective serotonin reuptake inhibitors (SSRIs) during late pregnancy causes a very small increase in the risk of persistent pulmonary hypertension of the newborn (PPHN).

In Brief
Patients with Bipolar Disorder Commonly Take Dietary Supplements; Increased Mortality in Elderly Patients Lower with Second-Generation Antipsychotics

Season's Greetings
Highlights of the past year include the Supreme Court's upholding of the Affordable Care Act (ACA), new data on the role of inflammatory processes in the development of disease, and public policy changes concerning marijuana.

CME 2015
Please be sure to review the Continuing Medical Education (CME) posttest and evaluation for 2015, inserted in this month's issue.

Affiliated Links

The Journal of Clinical Psychiatry

The University of Arizona Health Sciences Center- Department of Psychiatry

American Academy of Child and Adolescent Psychiatry

American Association of Suicidology

American Psychiatric Association

American Society for Adolescent Psychiatry

American Society of Addiction Medicine

American Society of Clinical Psychopharmacology

Autism Society of America

Depression and Bipolar Support Alliance (DBSA)

National Alliance for Research on Schizophrenia and Depression (NARSAD)

National Alliance for the Mentally Ill

National Association of Alcoholism and Drug Abuse Counselors

National Institute of Mental Health

National Mental Health Association